Who owns LATIGO BIOTHERAPEUTICS?
- CUSIP Number: 517954103
Tip: Access positions for across all investors
Analyze quarterly positions in Latigo Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Latigo Biotherapeutics stock
Who bought or sold LATIGO BIOTHERAPEUTICS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| FMR | 2.9M | $48M | 100% | Sep 2026 |
|
| Standard Life Aberdeen | 936k | $16M | 100% | Sep 2026 |
|
| Sanofi | 673k | $11M | 100% | Sep 2026 |
|
| Geode Capital Management | 220k | $3.7M | 100% | Sep 2026 |
|
| Squarepoint Ops | 35k | $587k | 100% | Sep 2026 |
|
| Cambridge Investment Research Advisors | 14k | $232k | 100% | Sep 2026 |
|
| Citigroup | 1.2k | $20k | 100% | Sep 2026 |
|
| Nuveen | 389.00 | $7.0k | 100% | Sep 2026 |
|
| Jacobi Capital Management | 30.00 | $501.000000 | 100% | Sep 2026 |
|